BioCentury | Jul 20, 2018
Financial News

Provention raises $64M IPO

...Thursday through the sale of 16 million shares at $4 in an IPO underwritten by MDB Capital Group...
BioCentury | Jul 20, 2018
Financial News

Provention raises $64M IPO

...19 through the sale of 16 million shares at $4 in an IPO underwritten by MDB Capital Group...
BioCentury | May 11, 2018
Financial News

Provention plans IPO, reveals MacroGenics deal

...proposed on May 9 to raise up to $50 million in an IPO underwritten by MDB Capital Group...
BioCentury | May 10, 2018
Financial News

Provention plans IPO, reveals MacroGenics deal

...Inc. (Lebanon, N.J.) proposed to raise up to $50 million in an IPO underwritten by MDB Capital Group...
BioCentury | Jan 5, 2018
Financial News

Autoimmune company Cue raises $66.2 million IPO

...2 through the sale of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group...
BioCentury | Jan 2, 2018
Financial News

Cue spikes after pricing $66.2M IPO

...million through the sale of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group...
BioCentury | Dec 8, 2017
Financial News

Cancer company Cue Biopharma updates IPO plans

...Cue filed in September to raise up to $40 million in an offering underwritten by MDB Capital Group...
BioCentury | Nov 17, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...Cue emerged from stealth mode in January with a $16.4 million venture round led by MDB Capital Group...
BioCentury | Sep 29, 2017
Financial News

Cue Biopharma proposes $40M IPO

...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group...
BioCentury | Sep 22, 2017
Financial News

Cue Biopharma proposes $40M IPO

...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group...
Items per page:
1 - 10 of 15
BioCentury | Jul 20, 2018
Financial News

Provention raises $64M IPO

...Thursday through the sale of 16 million shares at $4 in an IPO underwritten by MDB Capital Group...
BioCentury | Jul 20, 2018
Financial News

Provention raises $64M IPO

...19 through the sale of 16 million shares at $4 in an IPO underwritten by MDB Capital Group...
BioCentury | May 11, 2018
Financial News

Provention plans IPO, reveals MacroGenics deal

...proposed on May 9 to raise up to $50 million in an IPO underwritten by MDB Capital Group...
BioCentury | May 10, 2018
Financial News

Provention plans IPO, reveals MacroGenics deal

...Inc. (Lebanon, N.J.) proposed to raise up to $50 million in an IPO underwritten by MDB Capital Group...
BioCentury | Jan 5, 2018
Financial News

Autoimmune company Cue raises $66.2 million IPO

...2 through the sale of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group...
BioCentury | Jan 2, 2018
Financial News

Cue spikes after pricing $66.2M IPO

...million through the sale of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group...
BioCentury | Dec 8, 2017
Financial News

Cancer company Cue Biopharma updates IPO plans

...Cue filed in September to raise up to $40 million in an offering underwritten by MDB Capital Group...
BioCentury | Nov 17, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...Cue emerged from stealth mode in January with a $16.4 million venture round led by MDB Capital Group...
BioCentury | Sep 29, 2017
Financial News

Cue Biopharma proposes $40M IPO

...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group...
BioCentury | Sep 22, 2017
Financial News

Cue Biopharma proposes $40M IPO

...Mass.) proposed to raise up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group...
Items per page:
1 - 10 of 15